TECHNOLOGIES AND PIPELINE
Constructs for Selective Access
Cell & Tissue Targeting
Our platform integrates distinct technology areas into a powerful engine for therapeutic candidate generation and product development.
Our proprietary translocation technology, TRANSINT, uses microbe-inspired scaffold design to engineer proteins capable of overcoming gastrointestinal epithelial barriers to achieve best-in-class biopharmaceutical transport efficiency and selective cell targeting. We are focusing on high value opportunities with superior pharmacological benefits due to the oral-GI route of administration. Our development pipeline has been carefully selected and is fueled by novel technologies for constructing, robustly validating, and developing therapeutic candidates to the clinic.
Applied Molecular Transport's unique product strategy is a result of novel insights into:
Molecule Engineering & Pharmacology
Oral Dosage Forms
Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.
Development & CMC